SQZ Biotechnologies (SQZ)
NYSE: SQZ
· Real-Time Price · USD
0.43
0.16 (59.26%)
At close: Jul 03, 2023, 7:00 PM
SQZ Biotechnologies Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | 178K | n/a | 12.02M | 3.13M | 3.01M | 2.87M | 12.35M | 4.75M | 4.54M | 5.45M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | 178K | n/a | 12.02M | 3.13M | 3.01M | 2.87M | 12.35M | 4.75M | 4.54M | 5.45M |
Operating Income | -23.8M | -17.11M | -18.25M | -14.03M | -23.1M | -22.5M | -21.05M | -11.82M | -22.46M | -19.08M | -15.41M |
Interest Income | 164K | 340K | 505K | 615K | 436K | 156K | 15K | 8K | 8K | 11K | 9K |
Pretax Income | n/a | -16.77M | -17.69M | -13.55M | -22.64M | -22.24M | -21.04M | -11.82M | -22.45M | -19.07M | -15.4M |
Net Income | n/a | -16.77M | -17.12M | 30.49M | -22.19M | -22.24M | -21.04M | -11.82M | -22.45M | -19.07M | -15.4M |
Selling & General & Admin | 5.61M | 4.56M | 5.28M | 5.53M | 6.92M | 6.96M | 6.91M | 6.97M | 6.69M | 5.93M | 6.12M |
Research & Development | 10.5M | 12.73M | 12.98M | 15.58M | 19.63M | 18.76M | 17.01M | 17.21M | 20.52M | 17.68M | 14.74M |
Other Expenses | 7.68M | -2K | 63K | 75K | -322K | 111K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 23.8M | 17.29M | 18.25M | 21.19M | 26.23M | 25.51M | 23.92M | 24.18M | 27.21M | 23.61M | 20.86M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 23.8M | 17.29M | 18.25M | 21.19M | 26.23M | 25.51M | 23.92M | 24.18M | 27.21M | 23.61M | 20.86M |
Income Tax Expense | n/a | -340K | -568K | -44.04M | -455K | -156K | n/a | 9K | 6K | 6K | 7K |
Shares Outstanding (Basic) | 29.49M | 29.49M | 29.49M | 28.81M | 29.28M | 28.37M | 28.15M | 28.05M | 28.05M | 27.92M | 26.26M |
Shares Outstanding (Diluted) | 29.49M | 29.49M | 29.49M | 28.81M | 29.28M | 28.37M | 28.15M | 28.05M | 28.05M | 27.92M | 26.26M |
EPS (Basic) | n/a | -0.57 | -0.58 | 1.06 | -0.76 | -0.78 | -0.75 | -0.42 | -0.8 | -0.68 | -0.59 |
EPS (Diluted) | n/a | -0.57 | -0.58 | 1.06 | -0.76 | -0.78 | -0.75 | -0.42 | -0.8 | -0.68 | -0.59 |
EBITDA | -23.8M | -14.87M | -15.2M | -5.78M | -20.25M | -19.82M | -18.3M | -9.11M | -19.67M | -16.34M | -12.6M |
EBIT | n/a | n/a | n/a | -13.72M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Depreciation & Amortization | -39.59K | 2.24M | 3.05M | 8.25M | 2.85M | 2.69M | 2.75M | 2.71M | 2.78M | 2.73M | 2.8M |